The FDA Group Ranks #3 on Boston Business Journal's "FAST50" List with 892.78% growth from 2012 to 2015.
WESTBOROUGH, MA, May 18, 2016 — The Boston Business Journal recently ranked The FDA Group #3 on its list of 2016’s Fastest-Growing Private Companies in Massachusetts. In all, 76 companies were named to the list and the top 50 were designated as the “FAST50.”
"These companies represent the best examples of the Boston economy's strength and vibrancy," said Carolyn M. Jones, the BBJ’s publisher and market president. "This kind of top-line growth is driving the state's economy and generating the kind of excitement that attracts global brands and their talent here."
In order to qualify, companies must be privately held, Massachusetts-based businesses that recorded the highest revenue growth from 2012 through 2015. To be considered, companies needed a baseline of $1 million in revenue for 2015 and at least $500,000 in revenue for 2012.
At an awards breakfast on Thursday, April 21, the 76 companies were presented a plaque and given the opportunity to donate to the Special Olympics Massachusetts. More than 170 companies submitted nominations this year.
The FDA Group would like to thank the Boston Business Journal for this amazing honor and to its exceptional team for the amazing success we've enjoyed over the past few years.
More about the Boston Business Journal:
The Boston Business Journal is Greater Boston’s leading source of business news, information and events, reaching readers through the weekly print publication, the website bostonbusinessjournal.com and e-mail products. The BBJ also prints the annual Book of Lists — the region’s top resource for business decision-makers seeking information about potential clients, suppliers and partners.
The Boston Business Journal is published by American City Business Journals, the nation’s largest publisher of metropolitan business news.
More about The FDA Group
The FDA Group is a global leader in GxP auditing & remediation and regulatory services. They are in business for the purpose of providing a world-class service experience to the pharmaceutical, biotechnology, and medical device / diagnostics industries.
The way in which The FDA Group ensures a world-class service experience is by its proprietary talent selection process coupled with its deep-rooted corporate culture that includes 31 Fundamentals. These Fundamentals are the heart-beat of the organization and are focused on four areas: Core Values, Focus on Service, The Collaborative Way, and Personal Effectiveness.
For more information, contact:
Andrea Houlne
(508) 926-8330
info@thefdagroup.com